Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

NCT04332341 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Hematopoietic Cell Transplantation

Interventions

DRUG: Nicotinamide riboside (NR)

Sponsor

Case Comprehensive Cancer Center